Format

Send to:

Choose Destination
See comment in PubMed Commons below
Fertil Steril. 2009 Jan;91(1):167-72. doi: 10.1016/j.fertnstert.2007.11.036. Epub 2008 Feb 4.

Intravaginal and intracervical application of seminal plasma in in vitro fertilization or intracytoplasmic sperm injection treatment cycles--a double-blind, placebo-controlled, randomized pilot study.

Author information

  • 1Department of Gynecological Endocrinology and Reproductive Medicine, Women's University Hospital, University of Heidelberg, Heidelberg, Germany. michael.von.wolff@med.uni-heidelberg.de

Abstract

OBJECTIVE:

To evaluate whether intravaginal application of seminal plasma at the time of follicle aspiration in IVF or intracytoplasmic sperm injection treatment cycles has the potential to increase pregnancy rate. To calculate the number of patients needed to achieve significance in a multicenter trial.

DESIGN:

Double-blind, placebo-controlled randomized pilot study.

SETTING:

University department of gynecological endocrinology and reproductive medicine.

PATIENT(S):

One hundred sixty-eight patients undergoing IVF or intracytoplasmic sperm injection treatment.

INTERVENTION(S):

Cryopreserved seminal plasma from the patient's partner or sodium chloride (placebo) was injected into the cervix and the posterior fornix of the vagina just after follicle aspiration.

MAIN OUTCOME MEASURE(S):

Clinical-pregnancy rate.

RESULT(S):

One hundred sixty-eight patients agreed to participate in the study. Participation was limited to one treatment cycle. Thirty-one patients (18%) were excluded from the study, mainly as a result of canceled embryo transfers. Seventy patients received placebo, and 67 received seminal plasma. The clinical-pregnancy rate was 25.7% (18/70) in the placebo group. The clinical-pregnancy rate in the seminal plasma group reached 37.3% (25/67), corresponding to a relative increase of 45%.

CONCLUSION(S):

Even though significance was not reached in this pilot study, the data suggest that seminal plasma has the potential to improve pregnancy rate. It is estimated that around 450 patients need to be recruited to reach significance in a multicenter study.

PMID:
18249370
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk